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Abstract
Type 2 diabetes is a metabolic disorder which has been posed as a serious health problem 
in our present society. In light of the escalating prevalence of the disease and widespread 
evidence of progression to cardiovascular complications, there is a need to discover new 
agents to successfully treat this multifacet disorder.
Resistance to insulin-mediated glucose uptake and deregulation of lipid metabolism are 
early and major hallmarks in the development of type 2 diabetes. The aim of this thesis 
was to determine the effects and mechanisms of saponins of Panax notoginseng (SPN) 
on glucose and lipid metabolism. 3T3-L1 adipocytes was utilized to study whether this 
naturally occurring agent, which has been used in the treatment of ischemic cardio- 
cerebral vascular disease throughout China for years, improves insulin-mediated glucose 
uptake and lowers lipid levels in vivo.
3T3-L1 adipocytes were cultured and treated with 100 nM insulin alone or with 
concentrations of 10, 50, 100 and 200 pg/ml SPN, respectively. [3H]2-deoxyglucose 
glucose uptake, GLUT4 immunofluorescence imaging and glycogen synthesis assay were 
carried out to determine the effects of SPN on glucose metabolism. In addition, lipid 
staining and lipolysis assay were carried to study the effects of SPN on lipid metabolism.
The results in Chapter 2 indicate that SPN consist of properties that improve glucose 
metabolism in 3T3-L1 cells. SPN significantly increased insulin-mediated glucose uptake
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in a dose-dependent manner. Immunofluorescence imaging and analysis showed that SPN 
increased GLUT4 in the plasma membrane. Furthermore, glycogen synthesis augmented, 
whereby the incorporation of D-[U-I4C] glucose into glycogen was enhanced with SPN 
treatment in 3T3-L1 cells. These findings suggest that SPN may have a direct effect upon 
lowering glucose levels in type 2 diabetes.
Furthermore, results in Chapter 3 of this thesis illustrates that SPN also exert effects that 
regulate lipid metabolism. Lipid staining showed SPN significantly decreased lipid 
content 3T3-L1 adipocytes. In addition, SPN significantly inhibited lipolysis in vitro, 
indicating that this naturally occurring agent may decrease free fatty acid delivery to the 
liver thereby subsequently reducing hepatic glucose production.
In effort to discover a new anti-diabetic agent that achieves both treatment of type 2 
diabetes and prevention of diabetic complications, this study supports that SPN is a 
potential agent that is capable of directly lowering blood glucose and lipid levels in type 
2 diabetic patients. Further research with both in animal models and clinical trials, as 
described in Chapter 4, is needed to establish that SPN has high potential to be used as an 
agent for diabetes and its vascular complications. These findings may prove to be highly 
valuable to our society.
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